ETFs with FLML as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|6.11%||PowerShares Lux Nanotech Portfolio (PXN)||+0.08 (1.30%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Flamel Technologies is a specialty pharmaceutical company with a long history of expertise in drug delivery, focusing on the development of safer and more efficacious formulations, tackling unmet medical needs in the process. We are focusing on (1) the development and licensing of five versatile, proprietary drug delivery platforms (2) the development of novel, high-value products based on our drug delivery platforms and (3) as a result of our acquisition of Éclat Pharmaceuticals, LLC, or Éclat, the development, approval, and commercialization of niche branded and generic pharmaceutical products in the U.S. The Company’s versatile, proprietary drug delivery platforms are appropriate for more effectively and safely administering medicines to patients. ... More ...